points out that it is estimated around 20% of all scripts the US are for off-label indications, including serious conditions such as cancer and AIDS. In addition, it claims that federal, state and private health plans often pick up the tab for off-label drug uses, including the prescription of Botox - which is licensed for a variety of conditions such as wrinkles, certain eye disorders and excessi